Descartes-11 Consolidation Treatment in Patients With High-Risk Multiple Myeloma Who Have Residual Disease After Induction Therapy
Clinical trial NCT04436029 · COMPLETED
Trial details
- NCT number
- NCT04436029
- Sponsor
- Cartesian Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-24
- Primary completion
- 2022-02-18
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.